Mediwound Ltd. buy Ruckelsbuckel
Start price
13.08.22
/
60%
€1.97
Target price
13.08.23
€5.00
Performance (%)
-6.09%
End price
04.09.22
€1.85
Summary
This prediction ended on 04.09.22 with a price of €1.85. With a performance of -6.09%, the BUY prediction for Mediwound Ltd. by Ruckelsbuckel closed slightly in the red. Ruckelsbuckel has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Mediwound Ltd. | 3.846% | 3.846% | 63.636% |
| iShares Core DAX® | 2.594% | -1.158% | 14.782% |
| iShares Nasdaq 100 | 3.553% | -1.727% | 43.265% |
| iShares Nikkei 225® | 0.687% | -8.354% | 18.454% |
| iShares S&P 500 | 2.209% | -0.942% | 31.361% |
According to Ruckelsbuckel what are the pros and cons of Mediwound Ltd. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Undervalued
High Investments for future growth
ROE higher than 15% per year
Very good company culture
Leading role in innovation
Sustainability is very important
Stable Large shareholder and/or long term investor
Top 10 in its market
Good rating
Normal challenges to pay loans and raise capital
Strong uniques
Very differentiated customer and product portfolio
Growths faster than the competition
Well known brand
Very Future proof/growth oriented business model
Very capable Management
Cons
Very low/no dividend yield expected
very negative Cash Flow expected
Significant cyclical dependencies
High risks in the balance sheet
High risks for its business